ArticleJAMA psychiatry2020
Association Between Lifetime Affective Symptoms and Premature Mortality.
Article in JAMA psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- State care in childhood and adult mortality: a systematic review and meta-analysis of prospective cohort studies.The Lancet. Public health · 2022Pooled it
- How adolescent depressive symptoms are associated with premature mortality: Behavioral and socioeconomic pathways across the life course.European child & adolescent psychiatry · 2026Article
- First implementation of a collaborative care model for common mental disorders in primary care in France: fidelity of care manager intervention matters.BMC health services research · 2026Article
- Testing bidirectional associations of major depressive disorder with medical conditions: two-sample Mendelian randomization study.Npj mental health research · 2026Article
- Prospective trajectories of depression predict mortality in cancer patients.Journal of behavioral medicine · 2024Article
- Physical activity in adult users of inpatient mental health services: A scoping review.PloS one · 2024Article
- Moderating Effect of Grip Strength in the Association between Diabetes Mellitus and Depressive Symptomatology.Sports (Basel, Switzerland) · 2023Article
- Overcrowded housing during adolescence and future risk of premature mortality: a 28-year follow-up of 556,191 adolescents from Switzerland.The Lancet regional health. Europe · 2023Article
- The risk of all-cause mortality associated with anxiety: a retrospective cohort study using 'The Health Improvement Network' database.BMC psychiatry · 2023Article
- Body mass index categories and anxiety symptoms among adults aged ≥ 50 years from low and middle income countries.Wiener klinische Wochenschrift · 2023Article
- Polygenic Liability to Depression Is Associated With Multiple Medical Conditions in the Electronic Health Record: Phenome-wide Association Study of 46,782 Individuals.Biological psychiatry · 2022Article
- Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression.Translational psychiatry · 2022Article
- Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic.International journal of environmental research and public health · 2022Observational
- Individual-level determinants of depressive symptoms and associated diseases history in Turkish persons aged 15 years and older: A population-based study.Frontiers in psychiatry · 2022Article
- Prevalence and variability of current depressive disorder in 27 European countries: a population-based study.The Lancet. Public health · 2021Article
- A Tale of Two Solitudes: Loneliness and Anxiety of Family Caregivers Caring in Community Homes and Congregate Care.International journal of environmental research and public health · 2021Article
- Longitudinal Associations of Mental Disorders With Physical Diseases and Mortality Among 2.3 Million New Zealand Citizens.JAMA network open · 2021Article
- Neurologic and Immunologic Complications of COVID-19: Potential Long-Term Risk Factors for Alzheimer's Disease.Journal of Alzheimer's disease reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Importance: Associations between affective symptoms and mortality have been evaluated, but studies have not examined timing or cumulative exposure to affective symptoms over the life course. Objectives: To examine how lifetime accumulation and timing of affective symptoms are associated with mortality and identify potential explanatory factors. Design, Setting, and Participants: Data were obtained from the MRC National Survey of Health and Development (1946 British birth cohort), a socially stratified, population-based sample originally consisting of 5362 singleton births in England, Wales, and Scotland during March 1946. The cohort has been followed up 24 times, most recently in 2014-2015. Eligible participants included those flagged for mortality with affective symptom data available at a minimum of 3 time points (n = 3001). Data analysis was conducted from July 2016 to January 2019. Exposures: Affective symptoms were assessed at ages 13 to 15 years (teacher-rated questionnaire), 36 years (Present State Examination clinical semistructured interview), 43 years (Psychiatric Symptom Frequency questionnaire), and 53 years (General Health Questionnaire-28). Case-level affective symptoms were determined by those scoring in the top 16th percentile (ie, suggestive of a clinical diagnosis). Main Outcomes and Measures: Mortality data were obtained from the UK National Health Service Central Register from age 53 to 68 years. Results: Of 3001 study members (1509 [50.3%] female, 1492 [49.7%] male), 235 individuals (7.8%) died over a 15-year follow-up. After adjustment for sex, those who experienced case-level affective symptoms 1, 2, and 3 to 4 times had 76%, 87%, and 134% higher rates of premature mortality, respectively, compared with those who never experienced case-level symptoms. Case-level symptoms in adolescence only (ages 13-15 years) were associated with a 94% increased rate of mortality, which was unexplained after full adjustment for covariates (hazard ratio, 1.73; 95% CI, 1.10-2.72). Associations between participants with case-level symptoms multiple (2-4) times and mortality were predominately explained by adult health indicators and behaviors. For example, associations for those with case-level symptoms 3 to 4 times were most strongly attenuated by number of health conditions (32.1%), anxiolytic use (28.4%), lung function (24.6%), physical activity (23.9%), smoking (24.6%), antidepressant use (20.1%), diet (16.4%), pulse rate (12.7%), and adult social class (11.2%). Conclusions and Relevance: Lifetime accumulation of affective symptoms may be associated with an increased rate of mortality, with explanatory pathways dependent on the duration and timing of symptoms. Future research into causal pathways and potential points of intervention should consider affective symptom history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.